Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Exemestane|DRUG: Fulvestrant
Sponsor: Ohio State University Comprehensive Cancer Center
Collaborators: Pfizer